SCHEMBL20889481

SCHEMBL20889481

Oc1ccc(-c2nc3cnccn3c2NC2CCCCC2)cc1O

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 3/20 0.71
GAA P10253 6/20 0.70
ALDH1A1 P00352 5/20 0.70
MAPT P10636 5/20 0.70
KDM4E B2RXH2 4/20 0.70
HTT P42858 3/20 0.70
XBP1 P17861 1/20 0.70
GFER P55789 3/20 0.69
HPGD P15428 1/20 0.69
PIM1 P11309 2/20 0.68
AURKB Q96GD4 2/20 0.68
MEN1 O00255 2/20 0.68
LMNA P02545 2/20 0.68
TP53 P04637 2/20 0.68
CASP1 P29466 2/20 0.68
CASP7 P55210 2/20 0.68
KMT2A Q03164 2/20 0.68
SMN1; SMN2 Q16637 2/20 0.68
ALOX15 P16050 1/20 0.68
TSHR P16473 1/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20889739 0.91 ALOX5 (0.67) ALOX5GAAALDH1A1MAPTKDM4E
SCHEMBL20889551 0.88 GAA (0.66) ALOX5GAAALDH1A1MAPTKDM4E
SCHEMBL20889277 0.88 ALOX5 (0.79) ALOX5GAAALDH1A1MAPTKDM4E
SCHEMBL20889737 0.84 GAA (0.85) ALOX5GAAALDH1A1MAPTKDM4E
SCHEMBL20889510 0.83 GAA (0.74) ALOX5GAAALDH1A1MAPTKDM4E
SCHEMBL20889736 0.83 GAA (0.68) ALOX5GAAALDH1A1MAPTKDM4E
SCHEMBL20889480 0.83 ALOX5 (0.79) ALOX5GAAALDH1A1MAPTKDM4E
SCHEMBL20889688 0.83 ALOX5 (0.79) ALOX5GAAALDH1A1MAPTKDM4E
SCHEMBL20889535 0.83 ALOX5 (0.74) ALOX5GAAALDH1A1MAPTKDM4E
SCHEMBL27104684 0.82 PIM1 (0.87) ALOX5GAAALDH1A1MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11530209-B2 Small molecule inhibition of transcription factor SALL4 and uses thereof DANA-FARBER CANCER INSTITUTE, INC. (US) 2022-12-20 US disclosed
US-20200317664-A1 SMALL MOLECULE INHIBITION OF TRANSCRIPTION FACTOR SALL4 AND USES THEREOF NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2020-10-08 US disclosed
WO-2019070943-A1 SMALL MOLECULE INHIBITION OF TRANSCRIPTION FACTOR SALL4 AND USES THEREOF DANA-FARBER CANCER INSTITUTE, INC. (US) 2019-04-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11530209-B2 Small molecule inhibition of transcription factor SALL4 and uses thereof SALL4, GLI2, TCF4 ALOX5 3823/4885GAA 3761/4885ALDH1A1 1038/4885
US-20200317664-A1 SMALL MOLECULE INHIBITION OF TRANSCRIPTION FACTOR SALL4 AND USES THEREOF SALL4, GLI2, TCF4 ALOX5 3823/4885GAA 3761/4885ALDH1A1 1038/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.